Chad T. Campbell

SVP & GM, Global Oncology and Vascular AccessatAngiodynamics· In proxies 2021–2024

Pay in FY2024+30% from the year before · Angiodynamics stock -33.3% the same year

Chad T. Campbell was paid $1.0M in FY2024 (May), up 30%. Angiodynamics stock fell 33.3% that year.

Pay$100 in the stock at the end of FY20 → $62

Pay is from the Summary Compensation Table of each Angiodynamics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

ANGO
AngiodynamicsPublic company · 5 yr
- SVP & GM, Global Oncology and Vascular Access2021 – Present · 5 yrStock in role +8%

Roles come from the proxy statements of each company.

Activity

Pay
Angiodynamics Division head pay rose 30% to $1.0M. The stock fell 33% in FY2024 (May).
DEF 14ASep 26, 2024
Pay
Angiodynamics Division head pay rose 21% to $1.0M. The stock fell 15% in FY2022 (May).
DEF 14ASep 26, 2024
Pay
Angiodynamics Division head pay fell 25% to $778.0K. The stock fell 52% in FY2023 (May).
DEF 14ASep 28, 2023

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?